In English
NIDA

NIDA Notes Advanced Search

Specific Drugs

Drug Topics

Temas relacionadas

Do you like these search results?

See all RSS Feeds

Your search for HIV or AIDS returned 31 results. Search again.

Treatment

New Approach Uses Immune Cells To Deliver Anti-HIV Medications

Nano-antiretroviral therapy (nano-ART) turns macrophages—one of the very cell types that HIV uses to replicate and spread through the body—into carriers for anti-HIV medications. The approach has the potential to make treatment for HIV easier and more effective.

Prevention

Expanded HIV Screening Projected To Decrease Spread of the Virus

Intensified screening for HIV among injection drug users receiving opioid agonist therapy could prevent more than twice as many new infections as current screening practice. A recent study based on mathematical modeling found that screening every 6 months instead of annually, and adding viral RNA testing to the currently used HIV antibody testing, could improve both effectiveness and cost-effectiveness.

Treatment

Study: Treat Jail Detainees’ Drug Abuse To Lower HIV Transmission

Active drug use before incarceration was associated with decreased engagement in HIV treatment among HIV-infected jail detainees. The severity of drug dependence correlated with worsening measures of engagement in HIV treatment. The study concludes that evidence-based treatment for drug abuse in jails may result in improved HIV treatment outcomes, which in turn could help slow HIV-transmission rates in the United States.

Treatment

HIV Infection Accelerates Hepatitis C–Related Liver Fibrosis

Study patients with HIV­­–hepatitis C coinfection progressed to successive degrees of severity of liver fibrosis 9 years sooner than those infected with HCV alone. Further findings from the study suggest that suppressing HIV with antiretroviral medications may slow HCV-related liver fibrosis.

NIDA @ Work

Dr. Marilyn Huestis Q & A: Matching Drug Effects to Drug Concentrations

Dr. Marilyn Huestis of NIDA’s Intramural Research Program talks about conducting research on drug effects with human subjects, developing tests to help law enforcement identify drugged drivers, and an assay to help identify children whose prenatal exposure to anti-HIV drugs may put them at risk for adverse developmental outcomes.

Prevention

Study Endorses Onsite HIV Testing Without Risk Reduction Counseling

Patients were more likely to take a rapid HIV test when substance abuse treatment programs offered the test onsite rather than referred for offsite testing. Patients were equally likely to accept and learn their HIV status whether the offer of onsite testing was accompanied by 30 minutes of risk reduction counseling or by 5 minutes of brief information on the testing procedure. Onsite testing accompanied by brief information was cost effective, taking into account the projected lifetime costs of treatment and the gains in health and longevity for detected cases.

Bulletin Board

Deadline Approaching: U.S.-Mexico Drug Abuse Prevention Research Fellowship

Researchers interested in applying for the NIDA U.S.-Mexico Drug Abuse Prevention Research Fellowship need to submit application materials by April 1, 2013. 

Director's Perspective

Seek-Test-Treat-Retain To Stop the Spread of HIV

Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

Treatment

Antiretroviral Treatment Reduces Spread of HIV Among Injection Drug Users

Expanded use of antiretroviral therapy in British Columbia reduced the spread of HIV among injection drug users and others in the province.
NIDA @ Work

Women and Sex/Gender Differences Research Program

NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.
Bulletin Board

NIDA Recognizes Developer of a New Business Model for Science

Dr. Redonna K. Chandler of NIDA receives the Institute's 2011 Innovator Award for developing a method that fosters collaboration and data sharing on various studies of HIV in criminal justice populations.
Treatment

Prison Use of Medications for Opioid Addiction Remains Low

Describes results from a nationwide survey among correctional facilities on the use of opioid replacement therapy for people who are addicted to heroin.

Prevention

Intensive Interventions Reduce Risky Sexual Behaviors

Discusses research that compares multiple sessions of motivational and behavioral training with that of a single intervention among male and female substance abusers to reduce high-risk sexual behaviors.
Treatment

HIV Treatment Interruption Is Pervasive After Release From Texas Prisons

Describes a study revealing that HIV-infected prisoners in Texas often experience an interruption in treatment following their release and that assistance in filling out paperwork can reduce these interruptions.

Prevention

High, Persistent Rates of Risky Sexual Behaviors in Delinquent Youth

Reports study findings that show young people who have gotten into trouble with the criminal justice system report high rates of sexual behaviors that increase risk of HIV and other sexually transmitted infections.
Bulletin Board

Four Scientists Receive Avant-Garde Awards

Recognizes four scientists for the 2009 Avant-Garde Award for HIV research, an award intended to stimulate groundbreaking research for the prevention and treatment of HIV/AIDS in drug abusers.

Basic Science

Crack Cocaine Promotes Progression of HIV Infection to AIDS

Reports on two studies showing a high prevalence of HIV infection and more rapid progression to disability and death among drug abusers.
Bulletin Board

James A. Inciardi (1939-2009)

Remembers Dr. James A. Inciardi, founder and co-director of the Center for Drug and Alcohol Studies and professor at the University of Delaware, who died on November 23, 2009.
Director's Perspective

NIDA's 35th Anniversary: Science Focused on Solutions

Commemorates NIDA’s 35th anniversary and highlights some of the major accomplishments since the Institute’s inception in 1974.

Treatment

Study Gives Green Light to Antiretroviral Medications for HIV-Infected Injection Drug Users

Reports finding from a study showing that access to antiretroviral therapies, HAART in particular, can improve the health of HIV-infected patients who have a history of injection drug use.

Bulletin Board

Three Scientists Receive Grants for Innovative AIDS Research

Announces the recipients of the inaugural Avant-Garde Award for research to prevent and treat HIV/AIDS in drug abusers, Drs. Julio Montaner, Ileana Cristea, and Jerome Groopman.

Bulletin Board

Conferees Discuss Ways to Eliminate Disparities in Care

Presents highlights of a meeting summit to discuss ways to eliminate disparities in care, particularly as they relate to drug abuse and HIV.

NIDA @ Work

Research Addresses Needs of Criminal Justice Staff and Offenders

Highlights a project in which nine research centers collaborate with criminal justice partners to test science-based tools for integrating drug abuse treatment in prisons and probation and parole programs.

Treatment

Selenium Shows Promise as an Adjunct Therapy for HIV

Reports on a randomized controlled trial of HIV-infected men and women who, as a result of receiving selenium supplements, experienced lower HIV viral load and greater CD4 cell count.

Treatment

Morphine Speeds AIDS Onset in Monkeys

Highlights the work of investigators who discovered key ways in which morphine may accelerate the progression of AIDS in animal studies.

Bulletin Board

Researchers Report on Progress of NIDA's Southern Africa Initiative

Presents an update on NIDA’s Southern African Initiative, a program that aims to build research capacity and infrastructure in the area of addiction, particularly drug-related HIV transmission.

HIV Patients Show Better Immune Recovery With Early Initiation of HAART

Presents evidence that among men and women with HIV, those who received early initiation of HAART therapy, those with higher CD4+ levels, achieved better immune recovery.

Journal Highlights Global Nexus of Drug Abuse and HIV/AIDS

Reviews a journal supplement that compiles studies on drug-related HIV transmission, with a focus on injection drug use, in 16 different localities across the globe.

Latest Information on MDMA/Ecstasy, Steroids, and HIV/AIDS Is Available on NIDA's Web Site

Announces updates to research reports on MDMA/ecstasy and steroids and a new report on HIV/AIDS that provide the latest available information on drugs and drug-related topics.

Bulletin Board

NIDA's National Advisory Council Welcomes New Members

Introduces four new members to NIDA’s National Advisory Council on Drug Abuse, including Drs. Warren K. Bickel, Ellie E. Schoenbaum, and Marina E. Wolf, and Ms. Janet Wood.
NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas